top of page

PODCAST SERIES TITLE:

"HOCL Podcast"

EPISODE 7:

"HOCL and Ophthalmology"

GENEVA

So imagine you're about to go into a medical procedure.

 

CLAY

Okay.

 

GENEVA

And obviously, you know, you want the operating field to be completely uncompromisingly sterile. Like, you'd want the strongest chemical possible to wipe out every single microbe before the surgeon even makes a cut.

 

CLAY

Right, yeah, that's the standard goal.

 

GENEVA

What if the surgery is on your eyeball? I mean, you can't exactly sandblast a delicate camera lens and expect it to still take clear photos.

 

CLAY

No, you really can't.

 

GENEVA

And you definitely can't pour rubbing alcohol or, you know, harsh iodine onto an open cornea without some pretty severe consequences.

 

CLAY

It's true. And that actually highlights one of the most stubborn paradoxes in medicine. Because the human eye is, well, it's extraordinarily fragile.

 

GENEVA

Yeah.

 

CLAY

I mean, a microscopic grain of pollen can cause excruciating pain, right?

 

GENEVA

Oh, absolutely. We've all been there.

 

CLAY

So introducing a caustic burning antiseptic is inherently destructive to that delicate tissue. And for a really long time, the medical community just sort of accepted that sterilizing the eye meant causing some degree of collateral damage.

 

GENEVA

Right. And because early doctors realized they were basically, you know, using chemical weapons on the most sensitive organ we have, the whole field eventually pivoted hard toward antibiotics.

 

CLAY

Yeah, exactly.

 

GENEVA

It seemed like the perfect workaround, right? Like, kill the bacteria, spare the tissue. But we're doing a deep dive today into Chapter 7 of the Essential Guide to HOCL, which is hypochlorous acid.

 

CLAY

Yes.

 

GENEVA

And our mission today is really to explore how this naturally occurring molecule is completely upending eye care. Because this text makes it incredibly clear that the whole reliance on antibiotics has painted modern ophthalmology into a really dangerous corner.

 

CLAY

It has. It really has.

 

GENEVA

We are now seeing super bugs, like these highly resistant strains of Staphylococcus aureus, basically taking root right on the surface of the eye.

 

CLAY

Yeah. And the irony of all of this is that the eye isn't actually defenseless.

 

GENEVA

Really?

 

CLAY

No. We have a very robust built-in security system. So human tears actually contain a powerful enzyme called lysozyme.

 

GENEVA

Okay, lysozyme.

 

CLAY

Right. And its entire job is to patrol the ocular surface and actively dismantle the cell walls of invading bacteria.

 

GENEVA

Wait, okay, let's unpack this. If our tears are already full of these, you know, biological security guards trying to break down bacterial walls, why are they failing? Are the bacteria wearing armor or something?

 

CLAY

In a way, yes. They actually are.

 

GENEVA

Oh, wow.

 

CLAY

The reason natural lysozyme and even prescription antibiotic drops often fail comes down to the actual physical architecture of the infection.

 

GENEVA

Architecture.

 

CLAY

Yeah. Bacteria are not just floating around aimlessly. When they want to survive in a hostile environment, like an eye that is constantly blanking and washing them with enzymes, they organize.

 

They form what is called a biofilm.

 

GENEVA

Ah, okay. The source has spent a lot of time on biofilms and it sounds incredibly devious.

 

CLAY

It is.

 

GENEVA

These bacteria essentially attach themselves to a surface, like the base of your eyelashes, and they secrete this slimy protective dome over the entire colony.

 

CLAY

Yeah. In microbiological terms, that dome is an extracellular polymeric substance or an EPS.

 

GENEVA

EPS, which sounds like a mouthful, but if I'm picturing this right, it's basically like a microscopic Kevlar tarp made out of sugars and proteins and DNA.

 

CLAY

That is a highly accurate way to look at it. It's a self-produced shield. Underneath that shield, the bacteria actually alter their metabolism.

 

GENEVA

Really?

 

CLAY

Yeah, they share nutrients. They essentially build a fortified microscopic city in there.

 

GENEVA

So when a patient drops standard antibiotics into their eye to treat an infection, they aren't actually hitting the bacteria.

 

CLAY

No.

 

GENEVA

They are just throwing water balloons at a bunker. The antibiotics just bounce right off that Kevlar tarp.

 

CLAY

Exactly. Because antibiotics are designed to interrupt specific biological life processes.

 

GENEVA

Yeah.

 

CLAY

Like stopping a bacterium from replicating.

 

GENEVA

Right.

 

CLAY

But if the antibiotic molecule physically cannot penetrate the slime layer to even reach the bacteria, it's completely useless. And this is where hypochlorous acid, or HCL, completely flips the scrap.

 

GENEVA

Because of its structure.

 

CLAY

Yes. Its molecular structure allows it to do something that antibiotics simply cannot do.

 

GENEVA

Because it's completely uncharged, right. The text mentions this lack of an electrical charge is kind of the key to everything.

 

CLAY

It is the defining feature. So most traditional antiseptics and antibiotics carry an electrical charge, usually positive or negative. Now bacterial cell walls and the biofilms they produce are generally negatively charged.

 

GENEVA

Got it.

 

CLAY

So if you introduce a negatively charged chemical, it repels like two opposing magnets pushing away from each other.

 

GENEVA

Right, right.

 

CLAY

And if you introduce a positively charged chemical, it might stick to the outer surface, but it just gets bogged down. It can't penetrate deep into the structure.

 

GENEVA

So because HCL has a neutral charge, it just acts like a ghost walking through a wall. The biofilm's electrical defenses don't even register that it's there.

 

CLAY

Exactly. It slips right past those outer defenses. And once it penetrates the biofilm, its chemical nature takes over.

 

HCL is a very potent oxidant.

 

GENEVA

Okay, so what does that do?

 

CLAY

It rapidly oxidizes the proteins and polysaccharides that hold that slime layer together. It literally melts the structural glue of the biofilm. Wow.

 

The dome collapses, exposing the bacteria inside. And then the HCL oxidizes the bacterial cell membranes, destroying them in seconds.

 

GENEVA

That is wild. And there was a case in the text that really stood out to me illustrating this. It was a 62-year-old man named Rajiv.

 

CLAY

Ah, yes, Rajiv.

 

GENEVA

He had been dealing with blepharitis, which is this chronic, miserable inflammation of the eyelids, just constant redness, swelling, and a really uncomfortable crusting around his eyelashes.

 

CLAY

Yes, it's terrible.

 

GENEVA

And he had been applying traditional antibiotic ointments for a long time.

 

CLAY

Right. And Rajiv's experience is incredibly common. The antibiotic ointment likely provided temporary relief.

 

Because it kills some of them. Right. When you apply it, you are killing the planktonic bacteria.

 

GENEVA

Planktonic meaning the free-floating ones.

 

CLAY

Exactly. The ones outside the biofilm. So the redness goes down for a few days.

 

GENEVA

But the bunker was still there.

 

CLAY

The bunker remained completely intact. So the surviving bacterial colony just waited until Rajiv stopped using the ointment and replicated again. And the inflammation came roaring back.

 

GENEVA

It's like pulling the weed but leaving the root.

 

CLAY

Precisely.

 

GENEVA

But then his doctor swapped the antibiotics for a twice-daily HOCL eyelid spray. And by simply spritzing this on his closed eyes, he was chemically dissolving that biofilm dome.

 

CLAY

Yes.

 

GENEVA

The text noted his eyelid margins cleared up completely. And even his blurred vision improved. And what's wild is that he got this result with zero side effects.

 

Like no burning and obviously no contribution to antibiotic resistance.

 

CLAY

And that's huge. Because the mechanism that cured Rajiv's blepharitis is the exact same mechanism resolving a massive underlying cause of dry eye syndrome.

 

GENEVA

Oh, dry eye.

 

CLAY

Millions of people suffer from chronically dry, gritty eyes. And they spend a fortune on artificial teardrops. Those drops are just temporary moisture.

 

They don't fix the anatomical problem.

 

GENEVA

Because the tears are just evaporating too fast. If I remember the biology correctly from the book, our tear film has a water layer, but it's supposed to be coated in a very thin lipid layer, an oil layer, to lock the moisture in.

 

CLAY

That's correct. And that oil layer is secreted by the meibomian glands.

 

GENEVA

Meibomian glands.

 

CLAY

Right. Which are these tiny vertical channels lining the very edge of your eyelids. So every time you blink, a tiny amount of oil is squeezed out to coat the eye.

 

GENEVA

So if a bacterial biofilm sets up camp right on the edge of the eyelid, it basically forms a crust over the opening of those glands.

 

CLAY

Yeah.

 

GENEVA

It's like putting a wax seal on a bottle of olive oil. The eye is begging for moisture. The oil is right there.

 

But the biofilm has corked the bottle.

 

CLAY

That is a great analogy.

 

GENEVA

Yeah.

 

CLAY

And the result is that your aqueous tears evaporate into the air within seconds.

 

GENEVA

Which is why your eyes feel so gritty.

 

CLAY

Exactly. But by using an HOCL spray, you are dissolving that wax seal, the biofilm melts away, the meibomian glands open back up, and the natural flow of oil is restored.

 

GENEVA

You are treating the structural root cause of the dry eye, rather than just constantly re-wetting the surface.

 

CLAY

Exactly. It's such an elegant mechanical fix.

 

GENEVA

It really is. But everything we've talked about so far, you know, blepharitis, dry eye, these are chronic sort of slow-burning conditions. The sources also highlight how HOCL is being deployed for acute, highly contagious emergencies.

 

And for any parent listening, the most dreaded eye emergency is ping guy.

 

CLAY

Oh, absolutely. Conjunctivitis is notoriously difficult to manage in clinical settings.

 

GENEVA

Why is that?

 

CLAY

Well, when a patient, especially a young child, comes in with a red, weeping, inflamed eye, the doctor has to make a very quick judgment call. Is this caused by a bacteria? Or is it caused by a virus?

 

GENEVA

And viral conjunctivitis is often driven by adenoviruses, which the text paints as incredibly stubborn.

 

CLAY

Very stubborn. And adenoviruses are highly resilient. They can survive on surfaces like doorknobs, shared toys, or school desks for a remarkably long time.

 

GENEVA

Yikes.

 

CLAY

Yeah, they sweep through daycares and schools with intense speed.

 

GENEVA

And here's the massive blind spot in traditional eye care, right? We don't have prescription antiviral eye drops for adenoviruses.

 

CLAY

No, we don't.

 

GENEVA

Because viruses aren't alive in the way bacteria are. They don't have cell walls or metabolisms to disrupt. So an antibiotic drop is completely useless against them.

 

CLAY

Totally useless. Yet doctors routinely prescribe antibiotic drops for viral pink eye anyway.

 

GENEVA

Wait, really?

 

CLAY

Why? Partially because it's hard to definitively rule out bacteria on the spot and partially to prevent opportunistic bacteria from infecting the eye while the tissue is vulnerable and inflamed.

 

GENEVA

So it's like a just-in-case measure.

 

CLAY

Yeah, exactly.

 

GENEVA

But HOCL is broad-spectrum, meaning it doesn't care if the threat is a bacteria, a fungus, or a virus. It neutralizes adenoviruses right on the surface of the eye.

 

CLAY

It does.

 

GENEVA

But wait, how does it dismantle a virus if there's no cell wall to break down?

 

CLAY

Well, it comes down to the viral architecture. An adenovirus is essentially just a package of genetic material wrapped in a protein coat called a capsid.

 

GENEVA

A capsid, okay.

 

CLAY

Right. And when HOCL comes into contact with that virus, its oxidative power denatures the proteins in that coat.

 

GENEVA

It just warps it.

 

CLAY

It warps and destroys the physical structure of the virus, completely rendering it incapable of attaching to and infecting human cells.

 

GENEVA

That's amazing. There's a story in Chapter 7 about a five-year-old boy who was stuck in this miserable loop of recurrent pink eye.

 

CLAY

Right, I remember that one.

 

GENEVA

He'd catch it at school, get sent home, take a round of antibiotic drops. It would suppress the secondary symptoms. He'd go back to school and just catch it all over again.

 

CLAY

The microbial load on his eyelids and eyelashes was never truly being managed.

 

GENEVA

But introducing a daily HOCL spray broke the cycle. It continually neutralized the pathogens, both viral and bacterial, without exposing the child to constant, unnecessary courses of antibiotics.

 

CLAY

Which is so important for kids.

 

GENEVA

Absolutely. Which actually brings up a scenario that I think a lot of adults can relate to, contact lens hygiene.

 

CLAY

Oh, yes.

 

GENEVA

The text details a case with a 28-year-old graduate student named Sophie.

 

CLAY

Right.

 

GENEVA

So she pulled an all-nighter, fell asleep in her contacts, and woke up with keratitis, which is this severe, painful infection of the cornea.

 

CLAY

It's awful.

 

GENEVA

And historically, an inflamed, infected cornea gets hit with the heaviest antibiotics a doctor can find, right? Because the risk of permanent vision loss is so high.

 

CLAY

It is a really high-stakes situation. A corneal ulcer can develop very rapidly, and the scarring can permanently damage vision.

 

GENEVA

But her doctor bypassed the heavy antibiotics entirely and prescribed an HOCL spray.

 

CLAY

Yeah.

 

GENEVA

And it cleared the infection rapidly, she kept her vision, and she just started using the spray daily to clean her lenses and eyelids.

 

CLAY

It's a great outcome.

 

GENEVA

Yeah. And if she's dodging a heavy course of antibiotics just because she slept in her contacts, that feels like a massive win for the broader antibiotic resistance crisis. We aren't wasting the heavy artillery on a contact lens mishap.

 

CLAY

It is a critical shift in public health strategy.

 

GENEVA

Yeah.

 

CLAY

I mean, every single time a clinician can resolve a localized infection, like Sophie's keratitis or a child's pink eye, with a topical, non-resistant agent like HOCL, we preserve the efficacy of systemic antibiotics.

 

GENEVA

Right. Saving them for when we really need them.

 

CLAY

Exactly. We save those powerful drugs for life-threatening internal infections where we truly have no other options.

 

GENEVA

Okay. I want to push back on something here though, because we need to talk about the operating room.

 

CLAY

Okay. Let's do it.

 

GENEVA

Because it's one thing to spray a gentle mist onto a closed eyelid to dissolve a biofilm.

 

CLAY

Sure.

 

GENEVA

It's another thing entirely to use this during surgery.

 

CLAY

True.

 

GENEVA

If HOCL is literally an acid, hypochlorous acid, and we know it melts bacterial biofilms and denatures viral proteins, how is it not melting the human eye when a surgeon uses it to prep a patient for cataract surgery or LASIK?

 

CLAY

I know. It sounds crazy. It is probably the most counterintuitive aspect of the molecule.

 

GENEVA

Yeah, it really is.

 

CLAY

But it requires looking at exactly where HOCL comes from in nature.

 

GENEVA

Because it's not just made in a lab. Our own bodies manufacture it.

 

CLAY

That's the secret. Specifically, our white blood cells make it.

 

GENEVA

Really?

 

CLAY

Yeah. When your immune system detects an invading pathogen, specialized white blood cells called neutrophils rush to the site.

 

GENEVA

Neutrophils.

 

CLAY

Right. And they physically engulf the bacteria. And once the bacteria is trapped inside the cell, the neutrophil triggers what is called an oxidative burst.

 

GENEVA

An oxidative burst.

 

CLAY

Yes. It synthesizes hypochlorous acid on demand, flooding the trapped bacteria and destroying it instantly.

 

GENEVA

So it's an insider. It is literally our biological immune weapon.

 

CLAY

Yes, exactly. Human cells have evolved alongside this molecule for millions of years.

 

GENEVA

Oh, that makes sense.

 

CLAY

Because our own biology relies on it, human tissue is uniquely equipped to tolerate it, provided it is at the correct therapeutic concentration, of course.

 

GENEVA

Which the text notes is usually around, what, 50 to 100 parts per million at a neutral pH?

 

CLAY

Right. 50 to 100 parts per million. At that specific balance, it doesn't sting.

 

And it is highly biocompatible.

 

GENEVA

Wow.

 

CLAY

And this is a radical departure from traditional surgical prep. For decades, ophthalmic surgeons have relied on povidone iodine to sterilize the eye before making an incision.

 

GENEVA

And iodine is notorious for being awful for the patient.

 

CLAY

It is an incredibly harsh halogen. It burns, it stains the tissue yellow, and most concerningly, from a surgical perspective, it is cytotoxic.

 

GENEVA

Meaning it kills human cells just as happily as it kills bacterial cells.

 

CLAY

Exactly. When a surgeon makes a microscopic incision in the cornea, the body immediately sends in fibroblasts.

 

GENEVA

Fibroblasts.

 

CLAY

Think of fibroblasts as the microscopic construction workers of the immune system.

 

GENEVA

Okay, I like that.

 

CLAY

Their whole job is to lay down collagen and stitch that incision back together.

 

GENEVA

But if the entire area is drenched in iodine?

 

CLAY

The iodine kills the fibroblasts.

 

GENEVA

Oh man.

 

CLAY

It creates a highly toxic environment that actually delays the cellular healing process. You're basically trading rapid healing for sterility.

 

GENEVA

That brings us right back to the sandblasting a camera lens analogy. We are damaging the eye to save it from infection. Exactly.

 

But with HOCL, the text highlights a patient named Mr. Lee. He was a 70-year-old going in for cataract surgery. And instead of the iodine, the surgeon prepped his eye and flushed the surgical site with HOCL.

 

CLAY

Right. And the result is totally different. The surgical field remained absolutely sterile, neutralizing any risk of endophthalmitis.

 

GENEVA

Endophthalmitis.

 

CLAY

Yeah, which is a devastating internal eye infection that can cause blindness in a matter of days.

 

GENEVA

Oh, that's terrifying.

 

CLAY

It is. But crucially, Mr. Lee didn't experience the burning of the iodine.

 

GENEVA

And the construction workers, the fibroblasts, were left completely unharmed to do their jobs.

 

CLAY

Yes. Because after HOCL performs its oxidative action, breaking down the pathogens, the molecule itself degrades.

 

GENEVA

It degrades.

 

CLAY

Yeah, it destabilizes and turns into trace amounts of sodium chloride and water. Just salt water. Just salt water.

 

GENEVA

So it goes in, destroys the invading pathogens, leaves the human cells untouched, and then vanishes into salt water.

 

CLAY

Exactly.

 

GENEVA

There is no toxic residue left behind to trigger inflammation.

 

CLAY

None at all. It provides the dual benefit that surgeons have sought for a century. Absolute, uncompromising antisepsis combined with total tissue compatibility.

 

GENEVA

That's incredible.

 

CLAY

It doesn't just prevent infection. It actually creates the optimal, non-toxic environment for the eye to heal itself.

 

GENEVA

You know, when you step back and look at all of this, from a five-year-old's pink eye to a grandmother's dry eye, all the way to a high-stakes cataract surgery, it really feels like we've been approaching eye care backwards.

 

CLAY

It really does.

 

GENEVA

We spent decades synthesizing harsher and harsher chemicals or, you know, relying on antibiotics that eventually birthed superbugs.

 

CLAY

Yeah, ophthalmology spent a century searching for an agent that is broad-spectrum, able to dissolve biofilms, incapable of generating microbial resistance, and entirely non-irritating to delicate tissue.

 

GENEVA

And the solution wasn't a new synthetic drug.

 

CLAY

No.

 

GENEVA

The solution was isolating the exact mechanism the human immune system already perfected.

 

CLAY

Biomimicry at its finest.

 

GENEVA

Which leaves us with a pretty fascinating thought to walk away with, for everyone listening to this deep dive.

 

CLAY

What's that?

 

GENEVA

Well, if science has finally figured out how to bottle the exact molecule our white blood cells use to fight infection, and it's safe enough to spray directly onto an open, surgically-altered human eye, what else are we getting wrong? Think about the harsh, toxic synthetic chemicals sitting in our bathroom cabinets and underneath our kitchen sinks right now. How many of those primitive, scorched-earth chemicals could be entirely replaced simply by looking a little closer at the biomimicry of our own immune systems?

Summary

What if the same molecule your immune system uses to destroy pathogens could also help protect one of the most delicate organs in the human body?

 

In Episode 7, we take HOCL into ophthalmology and explore how hypochlorous acid is being presented as a remarkably versatile tool for eye care.

 

From blepharitis and dry eye to conjunctivitis, contact lens complications, and surgical preparation, this episode examines the possibility of replacing harsh antiseptics and overused antibiotics with chemistry that is already native to our biology.

 

The eye presents a unique medical challenge. It needs to be protected from microbes while also being treated with extreme care.

 

Traditional antiseptics such as alcohol and iodine can be harsh on delicate ocular tissue, while antibiotics create another problem when infections become resistant.

 

Yet the eye already has its own defense system.

 

Tears contain lysozyme, an enzyme that helps break down bacterial cell walls, while bacteria can protect themselves by forming biofilms on the eyelids and surrounding surfaces.

 

The episode dives deep into these biofilms and why they can make conventional treatment difficult. Bacteria can build a protective extracellular polymeric substance, creating a shield that allows the colony to survive while exposed bacteria are eliminated.

 

HOCL is explored as a different approach because its electrically neutral structure allows it to move through this protective environment, where its oxidative chemistry can break down the components holding the biofilm together and expose the bacteria underneath.

 

One of the most interesting applications discussed is chronic eyelid inflammation.

 

The episode follows the case of Rajiv, a patient with blepharitis who had been using antibiotic ointments with only temporary relief.

 

The discussion suggests that targeting the underlying biofilm with an HOCL eyelid spray helped clear the eyelid margins and improve his symptoms.

 

The conversation then moves to dry eye and the tiny meibomian glands responsible for producing the protective oil layer of the tear film.

 

If biofilm and debris block these glands, the eye's natural moisture barrier can become compromised.

 

The episode explores the idea that removing this buildup with HOCL may address part of the underlying problem rather than simply adding temporary moisture with artificial tears.

 

We also explore viral conjunctivitis, including adenovirus, and why antibiotics are of limited value against viral infections.

 

HOCL is presented as a broad-spectrum approach that can interact with viral proteins as well as bacterial structures.

​

A case involving a child with recurring pink eye illustrates the episode's larger argument: managing the microbial environment around the eye may help break cycles of repeated infection while reducing unnecessary reliance on antibiotics.

​

Then comes one of the highest-stakes scenarios: contact lens complications and corneal infection.

 

The episode discusses Sophie's case of keratitis after sleeping in her contact lenses and explores how localized HOCL treatment was used as an alternative approach while highlighting the broader goal of preserving antibiotics for situations where they are truly necessary.

 

Finally, we enter the operating room.

 

The episode examines the use of HOCL in ophthalmic surgery and compares it with traditional povidone-iodine preparation.

 

The discussion focuses on a central challenge of surgical antisepsis: eliminating pathogens without creating an environment that is unnecessarily hostile to the human cells responsible for healing.

 

Fibroblasts, for example, play an important role in rebuilding damaged tissue after an incision.

 

A cataract surgery case involving Mr. Lee brings this idea together.

 

The episode describes HOCL being used to prepare and flush the surgical site, with the claimed benefit of strong antimicrobial action alongside tissue compatibility.

 

It presents this as an example of biomimicry: instead of inventing an increasingly aggressive chemical weapon, medicine may be able to reproduce a defense mechanism the human body has already evolved to use.

 

From a child's pink eye to chronic dry eye and high-stakes eye surgery, Episode 7 asks whether the future of ophthalmology could lie in working more closely with the chemistry of our own immune system.

 

If our bodies already perfected a molecule capable of fighting microbes while working within delicate biological environments, how many other medical solutions might be hiding in plain sight?

Cover.png

THE ESSENTIAL GUIDE TO HOCL: NATURE'S HEALING MOLECULE Janice R. Goodman, DDS, MSc

Download e-book

"The Essential Guide to HOCL: Nature’s Healing Molecule"

By Janice R. Goodman, DDS, MSc

Chapter 7: HOCL and Ophthalmology

The Delicate Challenge of Ocular Medicine The human eye is one of the most sensitive organs in the body.

 

Even a speck of dust can cause discomfort, and harsh chemicals can cause permanent damage in seconds.

 

For centuries, this fragility limited the options doctors had for treating eye infections.

 

Traditional antiseptics -- iodine, silver nitrate, alcohol -- were far too caustic to use directly on the eye.

 

Antibiotics became the default, but their overuse has fueled resistant strains of Staphylococcus aureus and Pseudomonas aeruginosa, two of the most common culprits in eye disease.

 

Enter hypochlorous acid (HOCL) -- an antimicrobial so gentle it can be misted into the eye without irritation, yet strong enough to kill bacteria, viruses, and fungi within seconds.

 

For ophthalmology, this balance is a long-awaited breakthrough.

Why HOCL Works in the Eye

The eye already contains natural defenses: tears are rich in enzymes like lysozyme, which weaken bacterial walls.

 

But these are sometimes insufficient against aggressive infections.

 

HOCL complements these defenses by:
 

  • Rapid antimicrobial action against bacteria, viruses, fungi, and even spores.
     

  • No stinging or burning at therapeutic concentrations.
     

  • Reducing inflammation and soothing irritation.
     

  • Breaking down biofilms on eyelids and lashes, which often fuel chronic eye conditions.
     

Because HOCL is chemically identical to the molecule produced by white blood cells, the body recognizes it as natural rather than foreign.

 

Sophie, a 28-year-old graduate student, wears contact lenses daily.

 

After falling asleep with her lenses in, she develops a painful red eye. Her doctor diagnoses keratitis, a corneal infection.

 

Instead of defaulting to multiple rounds of antibiotics, Sophie’s doctor prescribes an HOCL eye spray. Within days, her symptoms ease.

 

The infection clears without damaging the cornea, and she continues wearing contacts safely -- now using HOCL spray as part of her daily routine to keep lenses and eyelids clean.

 

Common Ocular Conditions Treated with HOCL

 

  • Blepharitis: Chronic inflammation of eyelid margins caused by biofilms and bacteria. HOCL lid wipes break down biofilms, reducing redness, swelling, and crusting.
     

  • Conjunctivitis (“pink eye”): Whether bacterial or viral, HOCL spray reduces microbial load without antibiotic overuse.
     

  • Dry eye syndrome: HOCL reduces eyelid biofilms that block meibomian glands, restoring natural tear oils.
     

  • Post-surgical care: After cataract or LASIK surgery, HOCL reduces infection risk without irritating delicate tissues.
     

  • Contact lens hygiene: Sprays and solutions provide an additional layer of protection against keratitis.
     

Blepharitis is often caused not by single bacteria, but by biofilms -- communities of microbes forming sticky layers on eyelashes and eyelid margins.

 

These biofilms resist antibiotics and perpetuate chronic inflammation.

 

HOCL directly dissolves biofilms by oxidizing their protein and polysaccharide matrix.

 

This not only removes infection but also restores normal eyelid function, improving tear film quality and reducing irritation.

Conjunctivitis

A 5-year-old boy develops recurrent conjunctivitis after starting school. Standard antibiotic drops provide temporary relief, but infections keep returning.

 

His pediatric ophthalmologist recommends a daily HOCL eyelid and eye spray.

 

Over the next few months, the cycle breaks. The child has fewer infections, reduced redness, and no longer needs frequent antibiotics.

 

For his parents, HOCL means relief from constant school absences and doctor visits.

 

HOCL in Eye Surgery and Hospitals In ophthalmic surgery, sterility is paramount. Post-surgical infections like endophthalmitis are devastating, often leading to blindness.

 

HOCL has shown promise as:
 

  • A pre-surgical cleanser for eyelids and surrounding skin, safer than iodine.
     

  • A post-operative rinse to reduce microbial risk without harming healing tissues.
     

  • An adjunct to antibiotics in preventing resistant infections in hospital settings.
     

Because it breaks down into harmless salt water, HOCL also leaves no residue, unlike iodine staining or alcohol dryness.

 

Viral conjunctivitis, often caused by adenoviruses, spreads easily and has no specific antiviral treatment. HOCL offers unique advantages:

 

  • Rapidly inactivates viral particles on the eye surface.
     

  • Reduces secondary bacterial colonization.
     

  • Provides symptomatic relief by reducing redness and irritation.
     

This makes HOCL one of the few agents with both therapeutic and preventive potential against viral eye infections.

 

Mr. Lee, a 70-year-old retired teacher, undergoes cataract surgery. His ophthalmologist incorporates HOCL rinses before and after the procedure.

 

The surgical site remains pristine, with no signs of infection. Unlike iodine prep, there is no burning, and Mr. Lee’s recovery is smooth.

 

For him, HOCL made the difference between a stressful post-op period and a calm, rapid recovery.

Why HOCL Is Transforming Ophthalmology

Ophthalmology has long lacked an antiseptic that was both effective and tolerable for the eye. HOCL fills that gap, offering:
 

  • Powerful disinfection without toxicity
     

  • Support for healing, not interference
     

  • Potential to reduce antibiotic resistance
     

  • Applications from daily hygiene to surgery
     

What makes it especially exciting is accessibility: an HOCL spray is simple to use, safe for all ages, and affordable.

bottom of page